Jul 17, 2017
Startup Locus Biosciences Secures $5m Convertible Note for CRISPR-Cas3 Antimicrobials
Research Triangle Park-based Locus Biosciences has secured a $5 million convertible note. Chinese technology giant Tencent Holdings Limited led the financing round, which also included the N.C. Biotechnology Center. One…
